| Value | ₹47.00 Cr |
|---|
BSE filing, NSE: MUKKA. Summary written from the filing by ALFA Finder's alert engine.
Mukka Proteins Ltd: key numbers
- Share price
- ₹24.19
- Market cap
- ₹725.7 Cr
- Revenue (annual)
- ₹1,449 Cr
- Net profit (annual)
- ₹52.06 Cr
- P/E (TTM)
- 10.5×Sector 26.2×
- Promoter holding
- 73.33%+0.00% QoQ
- FII holding
- 1.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mukka Proteins Ltd
All →Mukka Proteins Regulatory Approval
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
- Execution
- October 1, 2026 to December 31, 2027
Mukka Proteins Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Mukka Proteins Production Started
Mukka Proteins Limited announced its subsidiary, United Gulf Fishery Products LLC, has commenced commercial production in Oman. The facility will produce fish meal and oil.
Mukka Proteins Debt & Borrowing: ₹73.58 Cr
Mukka Proteins Limited approved a corporate guarantee and SBLC worth Rs. 73.58 Crore for its subsidiary in Oman. The security supports credit facilities from HDFC Bank.
- Value
- ₹73.58 Cr
Mukka Proteins Credit Rating
CARE Ratings has reaffirmed the credit ratings of Mukka Proteins Ltd at CARE BBB-; Stable / CARE A3.
Mukka Proteins Credit Rating
CARE Ratings reaffirmed the credit ratings for Mukka Proteins Ltd's bank facilities totaling ₹495 Crore and revised the outlook from Negative to Stable.
- Value
- ₹495.0 Cr
Other annual general meeting announcements
All →Tasty Bite Eatables Annual General Meeting
Tasty Bite Eatables declared postal ballot results approving a material related-party transaction with Mars Food UK Limited for purchase of a capital asset. Promoter group did not vote and the resolution passed with 99.99% of votes cast in favour.
Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Vedanta Iron and Steel Annual General Meeting
Vedanta Iron and Steel seeks shareholder approval via postal ballot for seven material related party transaction resolutions. E-voting runs from 29 October to 27 November 2026.
GTPL Hathway Annual General Meeting
GTPL Hathway seeks shareholder approval by postal ballot to appoint Gurjeev Singh Kapoor as Non-Executive Director. E-voting runs November 1 to 30, 2026.
HEG Advanced Materials Annual General Meeting
HEG Advanced Materials seeks approval via postal ballot to appoint seven directors and fix MD Riju Jhunjhunwala's remuneration. E-voting runs October 29 to November 27, 2026.
Trident Texofab Annual General Meeting
Trident Texofab's EGM on 28 October 2026 sought approval for a statutory auditor to fill a casual vacancy. Only one ordinary resolution was tabled.